0.92
前日終値:
$1.0111
開ける:
$0.9895
24時間の取引高:
20,870
Relative Volume:
0.13
時価総額:
$8.68M
収益:
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-15.22%
1か月 パフォーマンス:
-37.84%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
Gelteq Ltd Stock (GELS) Company Profile
GELS を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
GELS
Gelteq Ltd
|
0.92 | 8.68M | 0 | 0 | 0 | 0.00 |
![]()
ZTS
Zoetis Inc
|
159.61 | 71.47B | 9.26B | 2.49B | 2.30B | 5.47 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
15.19 | 47.98B | 30.25B | 1.37B | 5.08B | 0.4257 |
![]()
HLN
Haleon Plc Adr
|
10.45 | 47.20B | 14.35B | 1.85B | 0 | 0.4023 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
14.85 | 17.02B | 16.54B | -1.64B | 749.00M | -1.45 |
![]()
UTHR
United Therapeutics Corp
|
307.36 | 13.80B | 2.76B | 1.11B | 898.10M | 22.77 |
Gelteq Ltd (GELS) 最新ニュース
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
CNS Pharma Stock Price, Quotes and Forecasts | NASDAQ:CNSP - Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Athira Pharma Stock Price, Quotes and Forecasts | NASDAQ:ATHA - Benzinga
Addex Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:ADXN - Benzinga
Gelteq introduces SportsGel with China deal in H1 2025 - Investing.com India
Gelteq introduces SportsGel with China deal in H1 2025 By Investing.com - Investing.com South Africa
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Gelteq Appoints Matthew Jones as Head of Sports Performance - GlobeNewswire Inc.
Gelteq Taps UAE Football, Boston Celtics Nutrition Expert to Lead Sports Performance Division - StockTitan
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Gelteq Strengthens Leadership with Renowned Scientist Dr. Paul Wynne as Chief Scientific Officer - StockTitan
“Gelteq has been continuously evolving to expand applications and audiences” - AlphaStreet
Gelteq Receives FDA Approval of its Suitability Petition for New Animal Drug - The Manila Times
Why C3.ai Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket - Benzinga
Gelteq CEO to Present at Benchmark's Discovery Investor Conference - StockTitan
The Benchmark Company Announces Upcoming Discovery One-on-One Investor Conference - The Manila Times
Why Credo Technology Group Shares Are Trading Higher By 40%; Here Are 20 Stocks Moving Premarket - Inkl
Oral drug and nutrient gel specialist soars after top client bumps up order by 50% - Mugglehead
NovoCure Limited (NASDAQ: NVCR): Groundbreaking PANOVA-3 Trial Results Signal Hope for Pancreatic Cancer Patients - BP Journal
Gelteq Limited (NASDAQ: GELS): Transforming Nutraceuticals with Gel-Based Innovation and Strategic U.S. Expansion - BP Journal
The Ascending Trajectory of Purple Biotech Ltd (PPBT): Pioneering Pancreatic Cancer Treatment with CM24 - BP Journal
Senti Biosciences, Inc. (SNTI) could keep surging and here’s why - BP Journal
Stock market news: Senti Biosciences +404.62%, Fossil Group +54.11% among top gainers during mid day trading - Business Upturn
Polyrizon Ltd.’s Quiet Period To End on December 9th (NASDAQ:PLRZ) - Defense World
Gelteq Limited’s (NASDAQ:GELS) Quiet Period To End on December 9th - Defense World
Gelteq (GELS) Ramps Up Production: 400,000 Gel Units Set for Global Distribution | GELS Stock News - StockTitan
Ins & OutsWeek Ending 11/15/2024 - substack.com
Gelteq Limited Appoints Adam Bendell as President of U.S. Operations - Marketscreener.com
Gelteq (GELS) Accelerates U.S. Growth, Appoints Former Deloitte Executive as President - StockTitan
Med-tech funding rises, driven by private investments and follow-ons - BioWorld Online
Gelteq Closes $5.2M IPO By Investing.com - Investing.com Australia
Gelteq launches IPO, raises $5.2 million for expansion - Investing.com India
Gelteq Limited Closes US$5.2 Million Initial Public Offering - The Manila Times
GELSGelteq Limited Ordinary Shares Latest Stock News & Market Updates - StockTitan
Argent Biopharma Lists New Shares on ASX - MSN
Biotech company Gelteq prices IPO at $4 per share - MSN
Vietnam Manufacturing & Export Processing to Announce Quarterly Results - MSN
Maas Group Reports Record Results and Growth Strategy - MSN
Qualitas Limited Releases 2024 Governance Statement - MSN
Biotech company Gelteq prices IPO at $4 per share (NASDAQ:GELS) - Seeking Alpha
WiseTech Investor Urges Progress, Transparency Amid CEO Scandal - MSN
Novatti Group Announces Hybrid Annual General Meeting - MSN
Gelteq Limited Prices US$5.2 Million Initial Public Offering - The Manila Times
RooLife Group Announces AGM with Key Resolutions - MSN
Ingram Micro IPO: Major tech product distributor debuts on NYSE today after pricing its stock within target range - MSN
Strike Resources Limited Announces Upcoming AGM Details - MSN
IPO Roundup: Ingram Micro Holdings, Peak Resources and more (NYSEARCA:IPO) - Seeking Alpha
Nathan Givoni & Simon Szewach on Gelteq - The Good Men Project
Aldebaran Financial Inc. Purchases 710 Shares of Invesco QQQ (NASDAQ:QQQ) - Defense World
Gelteq Ltd (GELS) 財務データ
Gelteq Ltd (GELS) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):